Cargando…

Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya

INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndede, Isaac, Mining, SK, Patel, K, Wanjala, FM, Tenge, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040314/
https://www.ncbi.nlm.nih.gov/pubmed/32127902
http://dx.doi.org/10.4314/ahs.v19i4.48
_version_ 1783500960591511552
author Ndede, Isaac
Mining, SK
Patel, K
Wanjala, FM
Tenge, C
author_facet Ndede, Isaac
Mining, SK
Patel, K
Wanjala, FM
Tenge, C
author_sort Ndede, Isaac
collection PubMed
description INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular microRNAs, non-coding RNAs have been reported to play role in cell cycle regulation. Both viral antigen dependent mutation and micro-RNA expression maybe involved in BL pathogenesis. OBJECTIVE: To describe immunoglobulin heavy variable (IgHV) rearrangement and micro-RNA expressions in BL tumours. METHODS: Genomic DNA were extracted and purified from BL tissue blocks at Moi Teaching and Referral Hospital, before amplification using IgHV consensus primers and sequencing. The sequences were then aligned with germline alleles in IMGT/V-QUEST® database. Total RNA extracted from tissue blocks and cell lines were used to determine relative expression of hsamiR-34a and hsa-miR-127. RESULTS: In all tumours, allele alignment scores and number of mutations range were 89.2–93.2%, 15–24 respectively. The range of IgHV amino acid changes were higher in EBER-1+ (15–25) than EBER-1- (9–15). In MYC+ tumours, the relative expression were: hsa-miR-127(2.09);hsa-miR-34a (2.8) and MYC- hsa-miR-127 (1.2), hsa-miR-34a (1.0). CONCLUSION: B-cell in BL contained somatic mutated IgHV gene and upregulated cellular microRNAs with possible pathogenetic role(s).
format Online
Article
Text
id pubmed-7040314
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-70403142020-03-03 Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya Ndede, Isaac Mining, SK Patel, K Wanjala, FM Tenge, C Afr Health Sci Articles INTRODUCTION: Burkitt's lymphoma (BL) is a virus associated childhood B-cell cancer common in Eastern Africa. Continued survival of B-cells in germinal centres depend on expression of high affinity immunoglobulins (Ig) to complementary antigens by somatic hypermutation of Ig genes. Cellular microRNAs, non-coding RNAs have been reported to play role in cell cycle regulation. Both viral antigen dependent mutation and micro-RNA expression maybe involved in BL pathogenesis. OBJECTIVE: To describe immunoglobulin heavy variable (IgHV) rearrangement and micro-RNA expressions in BL tumours. METHODS: Genomic DNA were extracted and purified from BL tissue blocks at Moi Teaching and Referral Hospital, before amplification using IgHV consensus primers and sequencing. The sequences were then aligned with germline alleles in IMGT/V-QUEST® database. Total RNA extracted from tissue blocks and cell lines were used to determine relative expression of hsamiR-34a and hsa-miR-127. RESULTS: In all tumours, allele alignment scores and number of mutations range were 89.2–93.2%, 15–24 respectively. The range of IgHV amino acid changes were higher in EBER-1+ (15–25) than EBER-1- (9–15). In MYC+ tumours, the relative expression were: hsa-miR-127(2.09);hsa-miR-34a (2.8) and MYC- hsa-miR-127 (1.2), hsa-miR-34a (1.0). CONCLUSION: B-cell in BL contained somatic mutated IgHV gene and upregulated cellular microRNAs with possible pathogenetic role(s). Makerere Medical School 2019-12 /pmc/articles/PMC7040314/ /pubmed/32127902 http://dx.doi.org/10.4314/ahs.v19i4.48 Text en © 2019 Ndede et al. Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Ndede, Isaac
Mining, SK
Patel, K
Wanjala, FM
Tenge, C
Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title_full Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title_fullStr Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title_full_unstemmed Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title_short Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya
title_sort immunoglobulin heavy variable (ighv) gene mutation and micro-rna expression in burkitt's lymphoma at moi teaching and referral hospital in western kenya
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040314/
https://www.ncbi.nlm.nih.gov/pubmed/32127902
http://dx.doi.org/10.4314/ahs.v19i4.48
work_keys_str_mv AT ndedeisaac immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya
AT miningsk immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya
AT patelk immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya
AT wanjalafm immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya
AT tengec immunoglobulinheavyvariableighvgenemutationandmicrornaexpressioninburkittslymphomaatmoiteachingandreferralhospitalinwesternkenya